▁Chron 9.2890625
ic 0.54736328125
▁pain 2.765625
▁is 1.1640625
▁still 6.71875
▁considered 3.990234375
▁to 1.9228515625
▁be 0.03277587890625
▁an 2.6796875
▁extreme 7.265625
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.156005859375
▁ 0.390380859375
8 3.474609375
% 2.189453125
▁of 0.12237548828125
▁the 0.5146484375
▁residents 6.63671875
▁of 0.7392578125
▁progress 12.6484375
ive 0.32080078125
▁countries 0.91796875
. 0.63671875
▁The 2.119140625
▁introduction 7.75390625
▁of 0.0309906005859375
▁the 2.359375
▁study 7.3203125
▁describes 7.28125
▁the 0.57568359375
▁apparent 8.9140625
▁between 10.953125
▁link 10.8828125
▁pain 4.6875
▁and 0.437255859375
▁dem 6.8671875
oral 3.798828125
ization 0.1494140625
. 1.0322265625
▁Chron 4.31640625
ic 0.0032863616943359375
▁pain 0.1405029296875
▁is 1.0419921875
▁always 5.42578125
▁accompanied 3.298828125
▁by 0.237060546875
▁negative 4.40625
▁emot 1.080078125
ional 1.455078125
▁experiences 3.26171875
▁and 2.126953125
▁blocks 11.6328125
▁a 3.509765625
▁person 0.83837890625
’ 0.97119140625
s 0.0018167495727539062
▁ability 1.4833984375
▁to 0.051239013671875
▁receive 6.9453125
▁joy 3.908203125
▁and 1.4423828125
▁satisfaction 3.384765625
▁from 0.92333984375
▁life 0.89404296875
. 0.270263671875
▁The 1.7333984375
▁research 2.755859375
▁investig 5.32421875
ates 0.482666015625
▁the 0.395263671875
▁development 6.33203125
▁of 0.1597900390625
▁de 3.474609375
pression 0.425048828125
▁and 1.4111328125
▁anx 1.7255859375
iety 0.001697540283203125
▁among 1.677734375
▁patients 1.5810546875
▁receiving 5.96875
▁op 3.400390625
io 0.05853271484375
ids 1.24609375
▁ph 7.1015625
arma 2.0859375
ce 0.0174560546875
ut 9.441375732421875e-05
ical 0.09197998046875
▁and 5.27734375
▁medical 3.796875
▁mar 2.525390625
iju 0.0018854141235351562
ana 0.00012493133544921875
▁( 3.1171875
MM 1.83203125
) 3.009765625
▁as 2.9609375
▁severe 9.84375
▁pain 0.8583984375
kill 3.111328125
ers 0.0009198188781738281
. 0.287109375
▁It 3.298828125
▁comp 5.36328125
ares 0.0095672607421875
▁the 0.6083984375
▁effic 4.50390625
acy 0.004039764404296875
▁of 0.2119140625
▁pres 6.203125
cri 1.4365234375
ptions 1.548828125
▁and 1.8583984375
▁exam 4.8046875
ines 0.0276947021484375
▁the 0.51416015625
▁possibility 4.01953125
▁of 0.1512451171875
▁post 8.3359375
- 0.705078125
tre 2.111328125
at 0.003673553466796875
ment 0.0100555419921875
▁de 1.87890625
pression 0.07635498046875
. 1.43359375
<0x0A> 0.8203125
There 4.515625
▁is 1.2578125
▁currently 5.93359375
▁a 1.08984375
▁severe 4.98046875
▁lack 2.103515625
▁of 0.0218048095703125
▁information 2.21875
▁about 1.1572265625
▁the 0.48095703125
▁effects 3.203125
▁of 0.06768798828125
▁op 2.607421875
i 3.802734375
ates 0.01535797119140625
. 3.384765625
▁They 4.59375
▁manage 8.203125
▁pain 2.984375
▁successfully 6.1015625
, 1.0048828125
▁but 0.2491455078125
▁the 2.494140625
▁past 8.890625
▁few 2.400390625
▁dec 1.443359375
ades 0.0008077621459960938
▁indicated 7.0546875
▁the 1.818359375
▁concern 7.51171875
▁growing 7.3515625
▁regarding 3.869140625
▁op 2.66015625
iate 1.369140625
▁ab 1.72265625
use 0.0225982666015625
▁in 3.849609375
▁forms 8.9609375
▁of 0.267333984375
▁over 3.564453125
d 0.1448974609375
ose 0.307861328125
▁and 0.79443359375
▁add 0.83154296875
iction 0.0281829833984375
. 0.1678466796875
▁A 3.9921875
▁more 5.00390625
▁manage 7.8125
able 0.002155303955078125
▁and 2.111328125
▁sa 2.169921875
fer 0.00022470951080322266
▁alternative 1.5126953125
▁might 5.12109375
▁be 0.12890625
▁medical 1.4443359375
▁mar 0.146240234375
iju 0.0011444091796875
ana 0.0001462697982788086
. 0.9365234375
▁However 3.478515625
, 0.0052032470703125
▁the 1.6943359375
▁legal 4.15234375
▁status 1.2294921875
▁and 3.134765625
▁novel 9.96875
ty 0.1624755859375
▁of 0.18896484375
▁this 2.21875
▁drug 1.537109375
▁do 4.33203125
▁not 0.0164642333984375
▁allow 0.76123046875
▁finding 6.73046875
▁a 2.47265625
▁large 2.685546875
▁number 0.802734375
▁of 0.0038013458251953125
▁on 8.625
▁studies 6.34765625
▁its 6.5625
▁effect 2.048828125
iveness 0.32470703125
. 0.80029296875
▁Specifically 9.125
, 0.0780029296875
▁it 2.568359375
▁concerns 5.0703125
▁the 0.89306640625
▁emot 6.49609375
ional 0.0255126953125
▁condition 4.4609375
▁of 0.322021484375
▁patients 0.7744140625
▁experien 5.2890625
cing 1.537799835205078e-05
▁chron 0.826171875
ic 0.0006971359252929688
▁pain 0.05908203125
. 0.451416015625
▁This 3.015625
▁research 1.982421875
▁paper 4.0078125
▁a 1.9970703125
ims 0.0008516311645507812
▁to 0.130126953125
▁analyze 3.31640625
▁levels 9.4296875
▁of 0.0305328369140625
▁de 0.58154296875
pression 0.03033447265625
▁and 0.23681640625
▁anx 0.040557861328125
iety 0.0008287429809570312
▁among 0.861328125
▁people 2.5078125
▁ther 10.375
apy 0.2086181640625
▁receiving 5.6875
▁by 7.59375
▁comparing 4.3828125
▁the 1.552734375
▁effects 2.3046875
▁of 0.048553466796875
▁ph 3.859375
arma 0.050811767578125
ce 0.0055389404296875
ut 0.00021696090698242188
ical 0.00777435302734375
▁op 0.99169921875
io 1.0234375
ids 0.06915283203125
▁and 0.283447265625
▁MM 0.5888671875
. 0.28271484375
<0x0A> 0.419189453125
The 0.80810546875
▁study 1.744140625
▁was 2.421875
▁conducted 0.69091796875
▁in 1.224609375
▁the 1.35546875
▁form 2.818359375
▁of 0.0059814453125
▁collection 11.2578125
▁and 0.94580078125
▁analysis 0.460205078125
▁of 0.029449462890625
▁data 1.2587890625
. 1.74609375
▁statistical 13.859375
▁Part 11.0
icip 0.50341796875
ants 0.054412841796875
▁were 0.818359375
▁rec 3.6953125
ru 0.0019216537475585938
ited 0.0004992485046386719
▁for 3.953125
▁six 6.4140625
▁months 0.41259765625
▁at 3.521484375
▁two 2.640625
▁pain 2.525390625
▁major 13.15625
▁relief 6.96484375
▁cent 0.75390625
ers 0.040283203125
▁in 0.94482421875
▁Israel 4.9765625
. 0.327392578125
▁The 1.2578125
▁research 2.5078125
ers 1.31640625
▁used 2.322265625
▁The 6.95703125
▁De 2.9921875
pression 0.028900146484375
▁Module 7.21484375
▁of 0.84375
▁the 0.2142333984375
▁Pat 3.55859375
ient 0.011810302734375
▁Health 0.044830322265625
▁Question 0.0276947021484375
naire 0.0275115966796875
▁and 2.728515625
▁the 0.63134765625
▁General 1.29296875
ized 0.66845703125
▁An 0.01035308837890625
x 0.00020110607147216797
iety 0.0005626678466796875
▁Dis 0.1790771484375
order 0.026702880859375
▁Sc 1.447265625
ale 0.002384185791015625
▁to 1.0546875
▁interview 7.26171875
▁participants 2.328125
, 4.2734375
▁evaluate 4.71484375
▁their 0.70361328125
▁answers 4.56640625
, 0.441162109375
▁and 0.05413818359375
▁conduct 4.92578125
▁the 1.693359375
▁study 2.259765625
. 0.125
▁specifically 10.0859375
▁evaluate 9.546875
▁To 7.21875
▁and 6.66015625
▁compare 2.833984375
▁the 0.599609375
▁prob 9.21875
abilities 0.0667724609375
▁of 0.1734619140625
▁de 1.07421875
pression 0.03759765625
▁or 4.24609375
▁anx 0.0828857421875
iety 0.0006036758422851562
▁among 1.6025390625
▁the 2.28515625
▁groups 2.607421875
, 1.662109375
▁diverse 11.328125
▁the 3.26171875
▁study 3.044921875
▁used 2.140625
▁multiple 5.49609375
▁log 1.0595703125
istic 0.037994384765625
▁regression 0.261962890625
▁analysis 1.345703125
▁and 2.671875
▁chose 8.390625
▁medical 5.78125
▁mar 0.2156982421875
iju 0.0020923614501953125
ana 0.00016939640045166016
▁as 0.6669921875
▁control 6.1015625
▁the 5.63671875
▁group 1.927734375
. 0.60009765625
<0x0A> 0.57080078125
This 4.26171875
▁type 6.5
▁of 0.05682373046875
▁study 1.263671875
▁is 1.3740234375
▁the 3.599609375
▁most 1.611328125
▁reve 8.40625
aling 0.004817962646484375
▁and 1.7314453125
▁inclus 7.1015625
ive 0.001445770263671875
, 2.841796875
▁as 1.4912109375
▁it 0.4375
▁contains 4.4921875
▁direct 6.30078125
▁responses 6.12890625
▁from 0.630859375
▁a 3.65234375
▁large 0.99560546875
▁number 0.460205078125
▁of 0.0129852294921875
▁participants 1.0947265625
. 0.6015625
▁All 5.21875
▁tools 7.85546875
▁in 5.4375
▁the 0.77880859375
▁form 3.791015625
▁of 0.06939697265625
▁question 0.7353515625
na 0.0169219970703125
ires 0.0007266998291015625
▁and 1.3212890625
▁scales 2.6953125
▁have 3.267578125
▁already 4.26953125
▁been 0.441650390625
▁used 2.18359375
▁and 1.765625
▁proved 2.59375
▁their 1.1650390625
▁effic 2.8203125
acy 0.0037288665771484375
▁for 3.779296875
▁collect 3.9921875
ing 0.00428009033203125
▁analyt 7.7265625
ical 0.1048583984375
▁data 0.25830078125
. 0.37109375
▁It 3.50390625
▁helps 4.10546875
▁to 0.67626953125
▁system 6.98828125
at 0.45751953125
ize 0.004627227783203125
▁and 1.341796875
▁class 4.5234375
ify 0.0040435791015625
▁distinct 8.5703125
▁kinds 6.61328125
▁of 0.021240234375
▁information 1.900390625
▁for 4.19921875
▁subsequent 4.90625
▁un 8.3984375
comp 4.109375
licated 0.0223846435546875
▁services 11.7734375
. 0.67333984375
▁Thus 4.859375
, 0.018157958984375
▁research 4.1484375
ers 0.3583984375
▁can 1.6083984375
▁compare 2.626953125
▁the 1.0
▁effects 2.9765625
▁medic 9.4140625
ations 0.71484375
▁of 3.359375
▁on 4.1875
▁patients 3.3125
▁of 4.02734375
▁diverse 4.34765625
▁age 2.63671875
▁groups 2.138671875
, 0.728515625
▁background 4.2890625
s 0.15185546875
, 0.041107177734375
▁conditions 5.546875
, 0.1146240234375
▁physical 6.84765625
▁emot 10.0234375
ional 0.042266845703125
▁states 2.419921875
, 0.1513671875
▁and 0.426025390625
▁so 2.53515625
▁on 0.1849365234375
. 0.0941162109375
<0x0A> 0.93359375
The 0.77197265625
▁analysis 4.09375
▁of 0.98193359375
▁any 9.140625
▁human 6.7890625
▁reaction 4.40625
▁has 4.57421875
▁a 1.814453125
▁high 3.22265625
▁potential 3.369140625
▁of 1.8935546875
▁subject 2.853515625
iveness 3.453125
▁and 1.3505859375
▁bias 1.869140625
, 2.125
▁especially 2.37109375
▁regarding 4.0390625
▁people 4.94140625
▁in 3.78125
▁severe 2.7578125
▁pain 0.646484375
▁and 2.240234375
▁un 5.609375
stable 1.1328125
▁emot 0.79345703125
ional 0.06231689453125
▁condition 2.255859375
. 0.0621337890625
▁Perhaps 7.99609375
▁some 4.890625
▁patients 2.1953125
▁tend 4.9140625
▁to 0.02276611328125
▁ex 2.009765625
agger 0.00959014892578125
ate 0.003742218017578125
▁their 1.0205078125
▁de 3.298828125
press 1.974609375
ive 0.08685302734375
▁state 2.607421875
▁or 1.658203125
▁vice 5.421875
▁vers 0.028900146484375
a 0.00010514259338378906
, 1.2021484375
▁de 7.35546875
- 2.765625
emph 0.495361328125
as 0.0042266845703125
ize 0.0716552734375
▁serious 6.86328125
▁difficulties 5.4765625
. 0.818359375
▁Because 6.29296875
▁the 2.5078125
▁survey 4.65234375
▁responses 6.87109375
▁were 1.439453125
▁thoroughly 9.0078125
▁anonymous 2.85546875
, 0.302978515625
▁the 1.263671875
▁research 0.96142578125
ers 0.1822509765625
▁were 2.58203125
▁unable 3.0078125
▁to 0.005802154541015625
▁carefully 8.046875
▁analyze 2.783203125
▁each 2.484375
▁patient 2.55859375
’ 0.5810546875
s 0.0022640228271484375
▁reaction 4.05859375
▁and 1.3818359375
▁compare 3.677734375
▁it 0.84765625
▁to 0.6865234375
▁the 0.9775390625
▁actual 4.31640625
▁states 7.5703125
▁of 0.86767578125
▁condition 6.44140625
. 0.4208984375
▁More 6.46484375
▁accurate 3.064453125
▁answers 4.58203125
▁could 1.8837890625
▁be 0.77099609375
▁obtained 1.0341796875
▁by 1.548828125
▁professional 6.171875
▁psych 1.2275390625
olog 0.4013671875
ists 0.002025604248046875
▁via 6.9609375
▁personal 2.61328125
▁communication 4.0703125
▁behavior 12.359375
al 1.5244140625
▁and 1.9921875
▁analysis 4.13671875
. 1.1943359375
▁However 2.857421875
, 0.00240325927734375
▁this 1.3798828125
▁method 2.26171875
▁of 2.74609375
▁research 1.990234375
▁is 1.130859375
▁way 6.06640625
▁more 0.80322265625
▁resource 4.7421875
- 0.3623046875
int 1.3056640625
ensive 0.0311279296875
▁and 0.43603515625
▁were 11.0234375
▁energy 10.7890625
- 1.0615234375
consum 0.6591796875
ing 0.005496978759765625
. 0.94140625
<0x0A> 0.48046875
Part 5.921875
icip 0.2335205078125
ants 0.117431640625
▁rec 5.609375
ru 0.07415771484375
ited 0.00016045570373535156
▁for 0.810546875
▁six 3.78125
▁months 0.041290283203125
▁at 0.5693359375
▁two 0.12890625
▁major 1.9091796875
▁pain 0.447265625
▁relief 0.2215576171875
▁cent 0.0860595703125
ers 0.00595855712890625
▁in 0.131103515625
▁Israel 0.020751953125
. 0.409912109375
▁All 3.533203125
▁patients 1.751953125
▁experienced 4.1484375
▁chron 0.63037109375
ic 0.0002579689025878906
▁pain 0.172119140625
▁for 2.25390625
▁at 0.65478515625
▁least 0.01092529296875
▁ 1.6669921875
3 1.4306640625
▁months 0.269287109375
. 1.138671875
▁The 1.443359375
▁study 1.876953125
▁included 1.7138671875
▁ 0.6201171875
8 2.986328125
9 2.49609375
0 3.142578125
▁participants 1.8857421875
, 1.3505859375
▁of 2.580078125
▁ 5.74609375
4 1.5751953125
7 2.787109375
4 2.662109375
▁which 5.94921875
▁( 4.35546875
5 0.1505126953125
9 5.25390625
%) 0.73291015625
▁were 1.2646484375
▁treated 2.7578125
▁sole 6.83984375
ly 0.0034427642822265625
▁with 0.366455078125
▁op 1.0693359375
io 0.2998046875
ids 0.1412353515625
, 0.81201171875
▁( 7.39453125
4 2.4296875
1 0.9912109375
%) 0.343994140625
▁ 5.71875
3 1.890625
2 1.5361328125
9 3.068359375
▁were 1.99609375
▁treated 1.1650390625
▁with 0.287353515625
▁MM 0.7470703125
, 1.767578125
▁and 0.400634765625
▁ 0.405517578125
7 3.15625
7 2.001953125
▁( 1.62890625
8 0.69091796875
. 1.11328125
6 1.248046875
%) 0.0841064453125
▁acquired 9.890625
▁both 0.701171875
▁( 4.875
Fe 9.53125
ing 1.205078125
old 0.42724609375
▁et 1.1240234375
▁al 0.0343017578125
., 0.1978759765625
▁ 0.0263214111328125
2 0.0087127685546875
0 0.0006175041198730469
1 0.356689453125
7 1.6806640625
). 0.06219482421875
▁The 1.3212890625
▁remaining 7.27734375
▁ten 7.15234375
▁participants 1.716796875
▁who 4.78125
▁did 2.201171875
▁not 0.037322998046875
▁receive 2.2890625
▁ph 3.9375
arma 0.10626220703125
ce 0.002483367919921875
ut 2.2649765014648438e-06
ical 0.0034313201904296875
▁op 2.470703125
io 0.10791015625
ids 0.042083740234375
▁and 2.6015625
▁medical 1.7529296875
▁mar 0.058074951171875
iju 0.0005421638488769531
ana 0.00011587142944335938
▁were 0.65380859375
▁with 6.484375
dra 0.2149658203125
wn 0.00010693073272705078
▁from 0.24853515625
▁the 0.1805419921875
▁analysis 2.296875
▁in 5.26171875
▁the 0.9921875
▁research 3.986328125
. 1.0439453125
▁Therefore 5.04296875
, 0.0255889892578125
▁it 3.857421875
▁is 1.533203125
▁not 2.9453125
▁possible 0.6728515625
▁to 0.0209503173828125
▁compreh 5.9140625
ens 0.1627197265625
ively 0.022705078125
▁compare 1.2666015625
▁patients 5.203125
▁taking 3.6640625
▁medic 4.02734375
ations 0.5166015625
▁with 1.7421875
▁those 1.177734375
▁who 0.98779296875
▁do 1.5166015625
▁not 0.027130126953125
. 0.62255859375
<0x0A> 0.60986328125
The 0.8740234375
▁study 1.80859375
▁conducted 4.09375
▁a 2.240234375
▁correlation 6.44140625
▁of 3.53125
▁type 8.6328125
▁research 7.73046875
▁with 5.328125
▁variable 7.9296875
▁measures 6.56640625
. 1.8515625
▁It 2.216796875
▁evaluated 4.05859375
▁the 0.6513671875
▁inter 6.80859375
dep 2.642578125
end 0.00052642822265625
ence 0.0089111328125
▁of 0.61962890625
▁various 3.580078125
▁factors 1.0458984375
▁that 2.689453125
▁affected 4.0390625
▁the 0.5048828125
▁physical 6.03515625
▁and 0.278564453125
▁emot 0.410888671875
ional 0.00024247169494628906
▁condition 1.5302734375
▁of 0.07281494140625
▁patients 0.74658203125
▁experien 2.880859375
cing 1.8715858459472656e-05
▁chron 0.23095703125
ic 0.0002970695495605469
▁pain 0.020843505859375
. 0.13818359375
▁For 3.740234375
▁example 0.80078125
, 0.00334930419921875
▁the 1.041015625
▁survey 5.5
▁showed 3.998046875
▁that 0.43115234375
▁the 1.8740234375
▁ratio 6.625
▁of 0.13037109375
▁female 3.56640625
▁patients 1.0205078125
▁was 1.26171875
▁remark 8.203125
ably 0.000469207763671875
▁in 8.65625
▁higher 2.72265625
▁the 3.625
▁op 4.48046875
i 3.126953125
ates 0.0166778564453125
▁group 0.5576171875
▁compared 2.673828125
▁to 0.171630859375
▁the 0.80224609375
▁MM 0.24267578125
▁group 0.38720703125
. 0.498779296875
▁In 3.384765625
▁turn 4.08984375
, 0.006069183349609375
▁people 4.875
▁on 4.1640625
▁op 2.701171875
i 0.84912109375
ates 0.00603485107421875
▁were 1.11328125
▁more 1.3251953125
▁likely 0.455322265625
▁to 0.07562255859375
▁report 2.876953125
▁major 6.19140625
▁de 0.419189453125
press 0.7431640625
ive 0.0024738311767578125
▁dis 0.88720703125
orders 1.79296875
. 1.6748046875
<0x0A> 2.30078125
The 0.97314453125
▁question 5.53125
na 1.05859375
ires 0.00021886825561523438
▁used 1.966796875
▁different 7.43359375
▁variable 8.1640625
▁measures 0.70703125
▁to 1.361328125
▁collect 2.697265625
▁information 1.53125
. 1.2744140625
▁For 1.818359375
▁example 0.20166015625
, 0.0031833648681640625
▁it 4.16796875
▁included 1.8583984375
▁compreh 8.265625
ensive 0.045257568359375
▁so 5.56640625
cio 0.01104736328125
- 0.251953125
dem 0.1175537109375
ographic 0.07025146484375
▁data 1.0380859375
: 4.76171875
▁gender 2.080078125
, 0.05450439453125
▁age 0.308349609375
, 0.036468505859375
▁country 4.3359375
, 2.48828125
▁type 4.1328125
▁of 0.14453125
▁residence 3.85546875
▁( 2.634765625
urban 0.8193359375
/ 1.4775390625
r 0.1773681640625
ural 0.0009565353393554688
), 0.192138671875
▁years 6.078125
▁of 0.210693359375
▁education 0.7265625
, 0.10675048828125
▁and 1.3994140625
▁employ 2.39453125
ment 0.0019073486328125
▁status 0.68994140625
. 0.1846923828125
▁also 7.58984375
▁Pat 7.1640625
ients 0.1260986328125
▁were 1.15625
▁asked 0.59326171875
▁about 1.1064453125
▁their 0.734375
▁medical 2.509765625
▁history 0.63134765625
▁over 8.078125
▁the 0.09527587890625
▁years 4.63671875
▁and 1.6298828125
▁the 1.5322265625
▁current 2.865234375
▁presence 5.16796875
▁of 0.1263427734375
▁any 2.333984375
▁severe 3.96875
▁dise 1.9970703125
ases 0.00022995471954345703
▁such 4.21484375
▁as 0.022674560546875
▁heart 2.6015625
▁failure 1.7744140625
, 0.279052734375
▁di 1.5908203125
ab 0.0007996559143066406
etes 0.002414703369140625
, 0.092529296875
▁ar 4.00390625
th 0.14697265625
rit 0.0215301513671875
is 0.005161285400390625
, 0.043487548828125
▁and 1.28125
▁so 0.83544921875
▁on 0.0380859375
. 0.05047607421875
▁The 1.7119140625
▁third 6.89453125
▁measure 3.6640625
▁of 2.720703125
▁the 0.947265625
▁question 1.84375
naire 0.2449951171875
▁was 1.2763671875
▁indicated 10.46875
▁by 1.888671875
▁information 6.53515625
▁on 2.021484375
▁any 5.703125
▁twelve 13.984375
- 0.330810546875
month 0.134765625
▁and 4.84765625
▁lifetime 1.0498046875
▁drug 3.2890625
▁and 1.5576171875
▁alco 0.137451171875
hol 0.00018024444580078125
▁consumption 4.30078125
. 0.461669921875
▁In 3.353515625
▁addition 0.89111328125
, 0.129150390625
▁the 0.9912109375
▁record 10.0078125
▁included 1.361328125
▁a 2.73046875
▁pain 4.40625
▁measurement 4.91015625
▁scale 0.93896484375
▁from 4.390625
▁ 0.55322265625
0 0.319580078125
▁to 0.23291015625
▁ 0.01340484619140625
1 0.07647705078125
0 0.037353515625
▁to 3.4140625
▁evaluate 1.7451171875
▁dis 5.9140625
com 0.14501953125
fort 0.0015382766723632812
▁feelings 7.3828125
▁during 4.24609375
▁the 0.294921875
▁last 1.0888671875
▁month 1.712890625
. 0.253662109375
<0x0A> 0.548828125
Am 6.06640625
ong 0.006488800048828125
▁all 2.47265625
▁participants 2.259765625
▁in 3.447265625
▁the 0.1900634765625
▁study 0.51708984375
, 0.0687255859375
▁ 0.85595703125
4 1.8857421875
2 2.6484375
. 1.126953125
2 2.208984375
% 0.0821533203125
▁suffered 3.744140625
▁from 0.0911865234375
▁de 1.5244140625
pression 0.2276611328125
, 0.97265625
▁and 0.98095703125
▁ 0.148193359375
3 1.453125
7 2.375
% 2.615234375
▁experienced 2.314453125
▁excess 7.109375
ive 0.03045654296875
▁anx 0.217041015625
iety 0.0020313262939453125
. 0.387451171875
▁The 1.4892578125
▁pl 10.53125
ur 0.580078125
ality 0.0011548995971679688
▁of 0.1444091796875
▁de 2.55859375
press 1.330078125
ive 0.031280517578125
▁dis 2.44140625
orders 0.08856201171875
▁among 3.1328125
▁patients 1.04296875
▁in 2.962890625
▁the 0.28173828125
▁op 0.6767578125
i 0.56103515625
ates 0.0022754669189453125
, 7.7734375
▁medical 4.37109375
▁mar 0.0601806640625
iju 0.0007534027099609375
ana 5.269050598144531e-05
, 0.54736328125
▁and 0.139404296875
▁mixed 1.6875
▁OP 10.71875
MM 4.125
▁groups 0.68408203125
▁number 8.6953125
ed 0.06640625
▁ 0.2203369140625
5 1.615234375
7 2.654296875
. 0.513671875
1 2.513671875
%, 0.248291015625
▁ 0.00939178466796875
2 2.427734375
2 2.658203125
. 0.11407470703125
3 2.279296875
%, 0.07073974609375
▁and 0.07763671875
▁ 0.006778717041015625
5 1.93359375
1 2.12890625
. 0.1505126953125
4 1.7333984375
%, 0.211669921875
▁respectively 0.033447265625
. 0.238037109375
▁The 1.41015625
▁of 11.15625
▁pl 5.625
ur 0.03985595703125
ality 0.00019216537475585938
▁anx 2.013671875
iety 0.03582763671875
▁contained 10.3359375
▁ 0.483642578125
4 1.16015625
8 2.48046875
. 0.1895751953125
4 2.21875
% 2.734375
▁among 2.716796875
▁OP 4.99609375
▁patients 6.3046875
, 0.27099609375
▁ 0.1011962890625
2 0.97314453125
1 2.453125
. 0.11260986328125
5 2.15234375
% 0.044708251953125
▁among 0.62255859375
▁MM 0.146240234375
▁patients 0.414306640625
, 0.0379638671875
▁and 0.020721435546875
▁ 0.041046142578125
3 1.4921875
8 1.87109375
. 0.12481689453125
7 2.232421875
% 0.027313232421875
▁among 0.269287109375
▁OP 2.07421875
MM 0.153076171875
▁participants 2.96875
. 0.265869140625
▁Pat 5.51953125
ients 0.0232391357421875
▁who 2.13671875
▁took 2.177734375
▁strong 9.8046875
▁op 0.6943359375
i 0.83642578125
ates 0.003246307373046875
▁were 1.1064453125
▁t 9.7578125
ended 0.73095703125
▁to 0.081787109375
▁place 9.65625
▁their 2.177734375
▁pain 1.3896484375
▁on 1.9111328125
▁a 0.71337890625
▁scale 1.564453125
▁of 0.453369140625
▁ 0.1275634765625
9 2.388671875
▁to 2.25390625
▁ 0.0247039794921875
1 0.00677490234375
0 0.007904052734375
▁( 2.6953125
Fe 1.705078125
ing 0.003932952880859375
old 0.0006995201110839844
▁et 0.0205535888671875
▁al 0.00574493408203125
., 0.016204833984375
▁ 0.006130218505859375
2 0.0006427764892578125
0 7.05718994140625e-05
1 0.002002716064453125
7 0.007904052734375
). 0.01357269287109375
▁They 4.55859375
▁were 1.7705078125
▁also 1.1640625
▁an 9.0390625
gu 4.34765625
ished 0.1845703125
▁em 5.95703125
otion 0.00832366943359375
ally 0.006206512451171875
▁and 1.05859375
▁react 7.65625
ed 0.03594970703125
▁rad 9.5703125
ically 0.0028171539306640625
▁neg 4.7578125
atively 0.0025653839111328125
▁to 0.201904296875
▁almost 5.6796875
▁all 1.4658203125
▁survey 3.955078125
▁questions 0.2744140625
. 0.300537109375
▁Pat 3.802734375
ients 0.006374359130859375
▁who 1.3740234375
▁took 1.6171875
▁only 3.890625
▁MM 0.451904296875
▁or 2.859375
▁mixed 2.279296875
▁medic 1.55859375
ations 0.2061767578125
▁course 12.5859375
▁had 2.63671875
▁a 1.369140625
▁significantly 2.876953125
▁more 3.2734375
▁stable 2.79296875
▁emot 0.95068359375
ional 0.0017614364624023438
▁state 0.5634765625
▁and 1.091796875
▁cop 6.72265625
ed 0.0305328369140625
▁with 0.4453125
▁pain 0.90625
▁more 1.8857421875
▁manage 6.640625
able 1.1298828125
. 0.281494140625
<0x0A> 0.29345703125
One 4.94921875
▁of 0.2509765625
▁the 0.01519775390625
▁major 2.955078125
▁limitations 2.314453125
▁the 5.4375
▁is 4.94921875
▁ins 6.140625
u 0.036651611328125
fficient 0.031341552734375
ly 3.5078125
▁high 4.09765625
▁rate 4.1171875
, 6.1796875
▁response 5.578125
▁ 4.87890625
5 2.08984375
7 3.064453125
% 1.7177734375
▁instead 9.8203125
▁of 0.129638671875
▁ 0.36962890625
7 2.98046875
0 0.52099609375
% 1.2900390625
▁( 2.7265625
Fe 0.59765625
ing 0.0022602081298828125
old 0.0004394054412841797
▁et 0.0160675048828125
▁al 0.0021877288818359375
., 0.0117034912109375
▁ 0.016571044921875
2 0.000560760498046875
0 0.000244140625
1 0.0008983612060546875
7 0.0032100677490234375
). 0.0260009765625
▁It 1.9462890625
▁can 3.03515625
▁be 0.86767578125
▁fairly 8.4609375
▁explained 1.9521484375
▁by 0.256591796875
▁the 0.34765625
▁weak 7.1484375
▁focus 7.03515625
▁of 0.76904296875
▁respond 5.13671875
ents 0.1163330078125
▁who 3.591796875
▁have 3.833984375
▁overcome 7.89453125
▁severe 2.03125
▁pain 0.64013671875
▁sens 7.51171875
ations 0.22705078125
▁and 0.95751953125
▁de 4.42578125
press 0.75537109375
ive 0.046234130859375
▁episodes 2.470703125
. 0.5087890625
▁It 2.888671875
▁is 0.92822265625
▁not 2.60546875
▁clear 3.5234375
▁how 1.8369140625
▁to 3.26171875
▁use 4.94921875
▁these 2.94921875
▁statistics 4.36328125
, 2.9765625
▁as 0.72216796875
▁they 1.9306640625
▁still 5.16796875
▁may 4.54296875
▁be 1.421875
▁relevant 5.640625
▁for 1.8203125
▁the 1.7109375
▁analysis 2.5390625
. 0.94482421875
▁overall 9.7578125
